PTG: (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid
PTG is a Ligand Of Interest in 2ZK1 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 2ZK1_PTG_A_1 | 2% | 18% | 0.441 | 0.752 | 1.37 | 2.16 | 2 | 3 | 7 | 0 | 100% | 1 |
| 2ZK1_PTG_B_2 | 2% | 24% | 0.38 | 0.658 | 1.3 | 1.81 | 2 | 3 | 6 | 0 | 100% | 1 |
| 2ZK2_PTG_A_477 | 5% | 43% | 0.345 | 0.761 | 1.3 | 0.92 | 3 | 1 | 11 | 0 | 100% | 1 |
| 2ZVT_PTG_B_2 | 1% | 30% | 0.366 | 0.593 | 1.46 | 1.32 | 4 | 4 | 10 | 0 | 100% | 1 |
| 6I5G_PTG_A_607 | 7% | 5% | 0.289 | 0.749 | 2.68 | 2.53 | 5 | 7 | 1 | 0 | 100% | 1 |
